Radiation-induced lung injury: current evidence
M Arroyo-Hernández, F Maldonado… - BMC pulmonary …, 2021 - Springer
Chemo-radiotherapy and systemic therapies have proven satisfactory outcomes as standard
treatments for various thoracic malignancies; however, adverse pulmonary effects, like …
treatments for various thoracic malignancies; however, adverse pulmonary effects, like …
Organs at risk considerations for thoracic stereotactic body radiation therapy: What is safe for lung parenchyma?
V Moiseenko, J Zhao, MT Milano, L Li, A Rimner… - International Journal of …, 2021 - Elsevier
Purpose Stereotactic body radiation therapy (SBRT) has become the standard of care for
inoperable early-stage non-small cell lung cancer and is often used for recurrent lung …
inoperable early-stage non-small cell lung cancer and is often used for recurrent lung …
[HTML][HTML] Impact of pretreatment interstitial lung disease on radiation pneumonitis and survival after stereotactic body radiation therapy for lung cancer
Introduction To investigate the impact of pre-existing radiological interstitial lung disease
(ILD) findings on the incidence of radiation pneumonitis (RP) and clinical outcomes after …
(ILD) findings on the incidence of radiation pneumonitis (RP) and clinical outcomes after …
Multi‐institutional dose‐segmented dosiomic analysis for predicting radiation pneumonitis after lung stereotactic body radiation therapy
T Adachi, M Nakamura, T Shintani… - Medical …, 2021 - Wiley Online Library
Purpose To predict radiation pneumonitis (RP) grade 2 or worse after lung stereotactic body
radiation therapy (SBRT) using dose‐based radiomic (dosiomic) features. Methods This …
radiation therapy (SBRT) using dose‐based radiomic (dosiomic) features. Methods This …
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
JY Chang, H Liu, P Balter, R Komaki, Z Liao, J Welsh… - Radiation …, 2012 - Springer
Background Stereotactic ablative radiotherapy (SABR) can achieve excellent local control
rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard …
rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard …
Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis
S Yamaguchi, T Ohguri, S Ide, T Aoki, H Imada… - Lung cancer, 2013 - Elsevier
Purpose To evaluate the toxicity and efficacy of thoracic stereotactic body radiotherapy
(SBRT) in patients with subclinical interstitial lung disease (ILD). Methods and materials One …
(SBRT) in patients with subclinical interstitial lung disease (ILD). Methods and materials One …
Complications from stereotactic body radiotherapy for lung cancer
Stereotactic body radiotherapy (SBRT) has become a standard treatment option for early
stage, node negative non-small cell lung cancer (NSCLC) in patients who are either …
stage, node negative non-small cell lung cancer (NSCLC) in patients who are either …
Intrafractional baseline shift or drift of lung tumor motion during gated radiation therapy with a real-time tumor-tracking system
S Takao, N Miyamoto, T Matsuura, R Onimaru… - International Journal of …, 2016 - Elsevier
Purpose To investigate the frequency and amplitude of baseline shift or drift (shift/drift) of
lung tumors in stereotactic body radiation therapy (SBRT), using a real-time tumor-tracking …
lung tumors in stereotactic body radiation therapy (SBRT), using a real-time tumor-tracking …
[HTML][HTML] Radiation pneumonitis after stereotactic radiation therapy for lung cancer
H Yamashita, W Takahashi, A Haga… - World journal of …, 2014 - ncbi.nlm.nih.gov
Stereotactic body radiation therapy (SBRT) has a local control rate of 95% at 2 years for non-
small cell lung cancer (NSCLC) and should improve the prognosis of inoperable patients …
small cell lung cancer (NSCLC) and should improve the prognosis of inoperable patients …
Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR)–An analysis of UK's …
A Saha, M Beasley, N Hatton, P Dickinson… - Radiotherapy and …, 2021 - Elsevier
Abstract Background Stereotactic Ablative Radiotherapy (SABR) is the standard treatment
for early-stage medically inoperable lung cancer. Predictors of radiation pneumonitis (RP) in …
for early-stage medically inoperable lung cancer. Predictors of radiation pneumonitis (RP) in …